Table of Contents

Articles

• You have access

  Pharmacokinetics of New Calcium Channel Antagonist Clevidipine in the Rat, Rabbit, and Dog and Pharmacokinetic/Pharmacodynamic Relationship in Anesthetized Dogs

  H. Ericsson, B. Tholander, J. A. Björkman, M. Nordlander and C. G. Regårdh

  Drug Metabolism and Disposition May 1999, 27 (5) 558-564;
• You have access

  Effect of Selected Antimalarial Drugs and Inhibitors of Cytochrome P-450 3A4 on Halofantrine Metabolism by Human Liver Microsomes

  B. Baune, V. Furlan, A. M. Taburet and R. Farinotti

  Drug Metabolism and Disposition May 1999, 27 (5) 565-568;
• You have access

  Induction of Human UDP Glucuronosyltransferases (UGT1A6, UGT1A9, and UGT2B7) by t-Butylhydroquinone and 2,3,7,8-Tetrachlorodibenzo-p-Dioxin in Caco-2 Cells

  Peter A. Münzel, Stefan Schmohl, Horst Heel, Katharina Kälberer, Barbara S. Bock-Hennig and Karl Walter Bock

  Drug Metabolism and Disposition May 1999, 27 (5) 569-573;
• You have access

  Metabolism of (R)-(+)-Pulegone and (R)-(+)-Menthofuran by Human Liver Cytochrome P-450s: Evidence for Formation of a Furan Epoxide

  Siamak C. Khojasteh-Bakht, Weiqiao Chen, Luke L. Koenigs, Raimund M. Peter and Sidney D. Nelson

  Drug Metabolism and Disposition May 1999, 27 (5) 574-580;
• You have access

  Disposition of Ivermectin and Cyclosporin A in CF-1 Mice Deficient in mdr1a P-Glycoprotein

  G. Y. Kwei, R. F. Alvaro, Q. Chen, H. J. Jenkins, C. E. A. C. Hop, C. A. Keohane, V. T. Ly, J. R. Strauss, R. W. Wang, Z. Wang, T. R. Pippert and D. R. Umbenhauer

  Drug Metabolism and Disposition May 1999, 27 (5) 581-587;
• You have access

  Characterization of the UDP-Glucuronosyltransferases Involved in the Glucuronidation of An Antithrombotic Thioxyloside in Rat and Humans

  Dorothy Pless, Jean Noel Gouze, Claire Senay, Regine Herber, Pierre Leroy, Veronique Barberousse, Sylvie Fournel-Gigleux and Jacques Magdalou

  Drug Metabolism and Disposition May 1999, 27 (5) 588-595;
• You have access

  Effect of Inhibitor Depletion on Inhibitory Potency: Tight Binding Inhibition of CYP3A by Clotrimazole

  Megan A. Gibbs, Kent L. Kunze, William N. Howald and Kenneth E. Thummel

  Drug Metabolism and Disposition May 1999, 27 (5) 596-599;
• You have access

  Selective Mechanism-Based Inactivation of Cytochromes P-450 2B1 and P-450 2B6 by a Series of Xanthates

  Stanislav Yanev, Ute M. Kent, Bozidarka Pandova and Paul F. Hollenberg

  Drug Metabolism and Disposition May 1999, 27 (5) 600-604;
• You have access

  Retigabine N-Glucuronidation and Its Potential Role in Enterohepatic Circulation

  Anita Hiller, Nghia Nguyen, Christian P. Strassburg, Qing Li, Harald Jainta, Birgit Pechstein, Peter Ruus, Jürgen Engel, Robert H. Tukey and Thomas Kronbach

  Drug Metabolism and Disposition May 1999, 27 (5) 605-612;
• You have access

  Metabolism of Retigabine (D-23129), a Novel Anticonvulsant

  Roland Hempel, Hubert Schupke, Patrick J. McNeilly, Kristina Heinecke, Christiane Kronbach, Christian Grunwald, Gottfried Zimmermann, Christian Griesinger, Jürgen Engel and Thomas Kronbach

  Drug Metabolism and Disposition May 1999, 27 (5) 613-622;
• You have access

  Metabolic Drug Interactions between Angiogenic Inhibitor, Tnp-470 and Anticancer Agents in Primary Cultured Hepatocytes and Microsomes

  Laurent Placidi, Erika Cretton Scott, Devin Eckoff, Steven Bynon and Jean-Pierre Sommadossi

  Drug Metabolism and Disposition May 1999, 27 (5) 623-626;
• You have access

  Absorption and Intestinal Metabolism of SDZ-RAD and Rapamycin in Rats

  Andrew Crowe, Armin Bruelisauer, Louise Duerr, Pierrette Guntz and Michel Lemaire

  Drug Metabolism and Disposition May 1999, 27 (5) 627-632;